Multikinase inhibitors

INCY 20 Pill - white capsule-shape, 16mm

Generic Name: ruxolitinib

Pill with imprint INCY 20 is White, Capsule-shape and has been identified as Jakafi 20 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of Myelofibrosis; Myeloproliferative Disorders; Polycythemia Vera; Graft-versus-host disease and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Jakafi (Ruxolitinib [ rux-oh-li-ti-nib ])-INCY 20-20 mg-White-Capsule-shape
Jakafi (Ruxolitinib [ rux-oh-li-ti-nib ])-INCY 20-20 mg-White-Capsule-shape

Jakafi
Generic Name: ruxolitinib [ rux-oh-li-ti-nib ]
Imprint: INCY 20
Strength: 20 mg
Color: White
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50881-0020
Inactive Ingredients: Microcrystalline cellulose, Lactose monohydrate, Silicon dioxide, Povidone, Sodium starch glycolate type A potato, Magnesium stearate,
Latest News
Related Drugs